product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-Bad (Ser136) Antibody
catalog :
9295S
quantity :
200 ul
price :
274 USD
clonality :
polyclonal
host :
rabbit
antigen modification :
phosphorylated
reactivity :
human, mouse, rat
application :
western blot, other
citations: 6
Published Application/Species/DilutionReference
  • western blot; human; fig 2b
Bresin A, Callegari E, D'Abundo L, Cattani C, Bassi C, Zagatti B, et al. miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model. Oncotarget. 2015;6:19807-18 pubmed
  • other; mouse; 1:500; fig s1
Chiang C, Uzoma I, Lane D, Memisevic V, Alem F, Yao K, et al. A reverse-phase protein microarray-based screen identifies host signaling dynamics upon Burkholderia spp. infection. Front Microbiol. 2015;6:683 pubmed publisher
Suman S, Johnson M, Fornace A, Datta K. Exposure to ionizing radiation causes long-term increase in serum estradiol and activation of PI3K-Akt signaling pathway in mouse mammary gland. Int J Radiat Oncol Biol Phys. 2012;84:500-7 pubmed publisher
Ranganathan S, Harmison G, Meyertholen K, Pennuto M, Burnett B, Fischbeck K. Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Hum Mol Genet. 2009;18:27-42 pubmed publisher
Fujita H, Utsumi T, Muranaka S, Ogino T, Yano H, Akiyama J, et al. Involvement of Ras/extracellular signal-regulated kinase, but not Akt pathway in risedronate-induced apoptosis of U937 cells and its suppression by cytochalasin B. Biochem Pharmacol. 2005;69:1773-84 pubmed
Gray M, van Buren G, Dallas N, Xia L, Wang X, Yang A, et al. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. J Natl Cancer Inst. 2008;100:109-20 pubmed publisher
product information
SKU :
9295S
Product-Name :
Phospho-Bad (Ser136) Antibody
Size :
200 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
M, (H, R)
Applications :
Western blot
Product-Category :
Apoptosis
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
Host :
Rabbit
Target :
Bad (Ser99) phosphate
Primary-Protein :
BAD
Alt-Names :
BAD,BBC2,BBC6,BCL-X/BCL-2 binding protein,BCL2-antagonist of cell death protein,BCL2-associated agonist of cell death,BCL2-binding component 6,BCL2-binding protein,BCL2L8,Bcl-2-binding component 6,Bcl-2-like protein 8,Bcl-XL/Bcl-2-associated death promoter,Bcl2 antagonist of cell death,Bcl2-L-8
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.